default author photo

Jeffrey N. Bruce

Columbia University - Irving Medical Center

Department of Medicine

William Black Building, 8th Floor BB8-801C

New York, NY NY 10032

United States

SCHOLARLY PAPERS

2

DOWNLOADS

121

TOTAL CITATIONS

2

Scholarly Papers (2)

A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's Disease

Number of pages: 58 Posted: 12 Mar 2024
Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Mount Sinai Health System - Department of Psychiatry, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University - Irving Medical Center, Columbia University, Columbia University, Columbia University - Department of Medicine, Columbia University - Irving Medical Center, Columbia University - Department of Pathology and Cell Biology, Columbia University - Irving Medical Center, Columbia University, Columbia University - Taub Institute for Research on Alzheimer's and the Aging Brain, Columbia University, Mount Sinai Health System - Department of Psychiatry, Columbia University - Department of Systems Biology, Columbia University - Irving Medical CenterColumbia University - Center for Translational and Systems Neuroimmunology, Columbia University Irving Medical Center - Division of Behavioral Medicine and Columbia University - Center for Translational and Systems Neuroimmunology
Downloads 52 (1,060,784)

Abstract:

Loading...

Human microglia, single cell, microglia subtypes, in silico drug screening, in vitro models for human microglial subtypes, mitochondrial phenotyping

A Pharmacological Toolkit for Human Microglia Identifies Topoisomerase I Inhibitors as Immunomodulators for Alzheimer's Disease

Number of pages: 54 Posted: 16 Jul 2024
Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Mount Sinai Health System - Department of Psychiatry, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University, Columbia University - Irving Medical Center, Columbia University, Columbia University - Department of Pathology and Cell Biology, Columbia University - Department of Medicine, Columbia University - Irving Medical Center, Columbia University - Department of Pathology and Cell Biology, Columbia University - Irving Medical Center, Columbia University, Columbia University - Taub Institute for Research on Alzheimer's and the Aging Brain, Columbia University, Mount Sinai Health System - Department of Psychiatry, Columbia University - Department of Systems Biology, Columbia University - Irving Medical CenterColumbia University - Center for Translational and Systems Neuroimmunology, Columbia University Irving Medical Center - Division of Behavioral Medicine, Columbia University - Center for Translational and Systems Neuroimmunology and Independent
Downloads 24 (1,445,011)
Citation 1

Abstract:

Loading...

Human microglia, single cell, microglia subtypes, in silico drug screening, in vitro models for human microglial subtypes, mitochondrial phenotyping

2.

An RNA-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment Resistant Malignancies

Number of pages: 55 Posted: 28 Mar 2022
Columbia University - Irving Medical Center, Memorial Sloan Kettering Cancer Center, Columbia University - Irving Medical Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center - Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Memorial Sloan Kettering Cancer Center, Columbia University - Department of Systems Biology, Columbia University - Herbert Irving Comprehensive Cancer Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Department of Medicine, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Department of Medicine, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Cambridge, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University - Irving Medical Center, Columbia University, Columbia University - Irving Medical Center, Columbia University - Department of Systems Biology, DarwinHealth, Inc., Memorial Sloan Kettering Cancer Center and Columbia University Irving Medical Center - Department of Systems Biology
Downloads 45 (1,121,190)
Citation 1

Abstract:

Loading...

precision cancer medicine, computational inference, drug prediction, patient derived xenograft, high throughput drug screen, protein activity, regulatory network, systems biology, VIPER, OncoTarget, OncoTreat, PLATESeq, breast cancer, sarcoma, meningioma, colon cancer, pancreatic cancer